Bharat Immunologicals Intrinsic Value
BIBCL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹40.93 | ₹36.84 - ₹45.02 | +108.3% | Book Value/Share: ₹20.47, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹5.89 | ₹5.30 - ₹6.48 | -70.0% | Revenue/Share: ₹2.09, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹23.75 | ₹19.00 - ₹28.50 | +20.9% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check BIBCL share price latest .
Valuation Comparison Chart
BIBCL Intrinsic Value Analysis
What is the intrinsic value of BIBCL?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Bharat Immunologicals (BIBCL) is ₹23.75 (median value). With the current market price of ₹19.65, this represents a +20.9% variance from our estimated fair value.
The valuation range spans from ₹5.89 to ₹40.93, indicating ₹5.89 - ₹40.93.
Is BIBCL undervalued or overvalued?
Based on our multi-method analysis, Bharat Immunologicals (BIBCL) appears to be trading below calculated value by approximately 20.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.11 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -20.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -13.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.05x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Bharat Immunologicals
Additional stock information and data for BIBCL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2023 | ₹11 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-42 Cr | ₹-42 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹12 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹34 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2019 | ₹-32 Cr | ₹-32 Cr | Negative Cash Flow | 3/10 |